agilon health inc.
| NYSE: AGL |
| Healthcare / Healthcare Providers & Services / USA |
| 43.25 | +0.5700 | +1.34% | Vol 3.78M | 1Y Perf 40.84% |
| Jun 18th, 2021 16:00 DELAYED |
| BID | 38.00 | ASK | 0.0000 | ||
| Open | 42.47 | Previous Close | 42.68 | ||
| Pre-Market | - | After-Market | - | ||
| - - | - -% |
| Target Price | 42.00 | Analyst Rating | — — 0.00 | |
| Potential % | -2.89 | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | — - | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | — - | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Market Cap | 16.90B | Earnings Rating | — | |
| Price Range Ratio 52W % | 91.38 | Earnings Date | - |
Today's Price Range 42.1744.83 | 52W Range 26.5044.83 |
Summary:
Neutral
| Technical Indicators: | Neutral |
| Moving Averages: | Neutral |
| Performance | |||
|---|---|---|---|
| 1 Week | 17.53% | ||
| 1 Month | 41.06% | ||
| 3 Months | - | ||
| 6 Months | - | ||
| 1 Year | 40.84% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | 19.80 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -10.28 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | - | |||
Return on invested Capital Q | - | |||
Return on invested Capital Y | - | |||
Assets Turnover | 2.70 | |||
Receivables Turnover | 7.00 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -240.10 | ||||
| - | ||||
| 11.15 | ||||
| - | ||||
| -279.00 | ||||
| -0.18 | ||||
| -35.84 | ||||
| -0.76 | ||||
| 14.38B | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.10 | ||||
| 1.10 | ||||
| - | ||||
| - | ||||
| -6.60 | ||||
| Leverage Ratio | -1.80 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 7.10 | ||||
| -4.40 | ||||
| -3.40 | ||||
| - | ||||
| -4.41 |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.34B | ||||
| 3.43 | ||||
| - | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q01 2021 | -0.04 | -0.04 | 0.00 |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | - |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 3.78M |
| Shares Outstanding | 390.83M |
| Trades Count | 13.50K |
| Dollar Volume | 0 |
| Avg. Volume | 797.42K |
| Avg. Weekly Volume | 1.09M |
| Avg. Monthly Volume | 812.97K |
| Avg. Quarterly Volume | 797.42K |
agilon health inc. (NYSE: AGL) stock closed at 43.25 per share at the end of the most recent trading day (a 1.34% change compared to the prior day closing price) with a volume of 3.78M shares and market capitalization of 16.90B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 552 people. agilon health inc. CEO is Steven J. Sell.
The one-year performance of agilon health inc. stock is 40.84%, while year-to-date (YTD) performance is %. AGL stock has a five-year performance of %. Its 52-week range is between 26.5 and 44.83, which gives AGL stock a 52-week price range ratio of 91.38%
agilon health inc. currently has a PE ratio of -240.10, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of 11.15, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -10.28%, a ROC of -% and a ROE of 19.80%. The company’s profit margin is -4.41%, its EBITDA margin is -3.40%, and its revenue ttm is $1.34 Billion , which makes it $3.43 revenue per share.
Of the last four earnings reports from agilon health inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. agilon health inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for agilon health inc. is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for agilon health inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
agilon health inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
agilon health inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 35.37, ATR14 : 2.02, CCI20 : 214.76, Chaikin Money Flow : 0.07, MACD : 2.38, Money Flow Index : 81.42, ROC : 14.81, RSI : 75.01, STOCH (14,3) : 85.02, STOCH RSI : 1.00, UO : 61.25, Williams %R : -14.98), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of agilon health inc. in the last 12-months were:
agilon health inc.
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
CEO: Steven J. Sell
Telephone: +1 562 256-3800
Address: 1 World Trade Center, Long Beach 90831, CA, US
Number of employees: 552
